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ABSTRACT
Objective: The objective of this study is to evaluate the antipsoriatic activity of aqueous extract of Brassica oleracea var. capitata leaves (BOAE) and 
ethanolic extract of Mentha spicata leaves (MSEE) on Imiquimod-induced Psoriasis-like dermatitis.
Methods: Imiquimod induction method for psoriasis-like dermatitis was used for the evaluation of antipsoriatic activity. Extracts were tested at 
a dose of 100 mg/kg body weight (b.wt.) and 400 mg/kg b.wt. in Swiss albino mice. These test doses were compared with the Retino-A (0.025%) 
treated group which serves as a standard group. Parameters studied in the test include changes in body weight, spleen weight and spleen index, 
neutrophils, lymphocytes, eosinophils, monocytes, hemoglobin, red blood cells, platelets, packed cell volume, mean corpuscular volume, mean 
corpuscular hemoglobin (MCH), MCH concentration, epidermal thickness, erythema, desquamation, skin thickness, superoxide dismutase, catalase, 
lipid peroxidation of skin and percentage orthokeratotic values, drug activity, and relative epidermal thickness.
Results: MSEE at dose of 400 mg/kg b.wt has shown more effect when compared with MSEE at low dose, BOAE topical and oral.
Conclusion: From the study, it was concluded that the above extracts have promising anti-psoriatic activity.
Keywords: Brassica oleracea var. capitata, Mentha spicata, Psoriasis, Imiquimod, Retino-A (0.025%).
INTRODUCTION
Psoriasis is a condition in which the skin cells build up characterized 
by red skin, scales, and dry patches resulting in severe itching. It is a 
chronic, painful disease for which there is yet no cure. Psoriasis is a 
disorder of the skin, which occurs when the immune system sends out 
faulty signals, resulting in the speeding-up of the skin cell cycle [1,2]. 
It is a noncommunicable disease which can occur at any age. It affects 
patients physically as well as mentally. Psoriasis involves the skin and 
nails and is also associated with a number of comorbidities. The reported 
prevalence of psoriasis in countries ranges between 0.09% and 11.4%, 
making it a serious global problem. The etiology of psoriasis still remains 
unclear [3]. Although there is a reported suggestion that psoriasis could 
be an autoimmune disease, no autoantigen that could be responsible 
has been defined yet. In psoriasis epidermal hyperproliferation, 
abnormal keratinocyte differentiation can be seen. However, the cause 
of the loss of control of keratinocyte turnover is idiopathic. Early and 
active psoriatic lesions are characterized by intraepidermal penetration 
of activated polymorphonuclear leukocytes, which causes uncontrolled 
release of reactive oxygen species (ROS) which leads to pre-oxidative 
damage of skin membranes, which worsens the condition by increasing 
the severity of the lesions. ROS activates phospholipase A2 and thus 
increase the release of the mediators of arachidonic acid. Prostaglandin 
produced by the cyclooxygenase pathway also contributes to psoriasis 
by dilating capillaries present in the dermis of the skin, stimulates 
keratinocyte cell growth and increase in leuckocyte infiltration [4].
Availability, affordability, side effects on prolonged usage of allopathic 
drugs have become a greatest concern for psoriasis. Hence, this 
study was aimed at assessing the antipsoriatic activity using herbal 
extracts of Brassica oleracea var. capitata and Mentha spicata leaves. 
These two plants are well-known plants. B. oleracea var. capitata 
is commonly known as cabbage and M. spicata plant is commonly 
known as spearmint. Both these plants are cultivated in India and 
has a wide usage. As B. oleracea var.capitata and M. spicata was used 
conventionally, but there is no reported data so an attempt was made 
to evaluate the antipsoriatic activity of B. oleracea var.capitata and M. 
spicata [5,6].
MATERIALS AND METHODS
Collection of plant materials
The fresh leaves of B. oleracea var. capitata were collected from the local 
market. The leaves of the M. spicata plant were collected from the 
agriculture area near Tirupati in Chittoor District, AP, India. Both the 
plants were authenticated by Dr. K Madhava chetty, Assistant Professor, 
Department of Botany, S.V University, Tirupati. Then the plants were 
washed with distilled water to remove dirt and soil. Then, the collected 
M. spicata plant leaves were dried under shade at room temperature for 
10–15 days. The dried plant leaves were powdered by using a grinding 
mill to obtain a coarse powder and then passed through 40 mesh sieve.
Preparation of plant extract (Mentha spicata)
The powdered material was subjected to extraction using ethanol 
by the solvent extraction method. Initially, 100 g of crude powder 
was taken and packed in a packing paper. This pack was placed in a 
Soxhlet extractor and extracted with ethanol, the extraction was carried 
out until the extract becomes colorless. The extract was then filtered 
with what man filter papers (No.1) and the filtrate was evaporated to 
dryness in a rotary evaporator at 40° [4]. The obtained crude extract 
was stored in a refrigerator at 4°C until the time of use.
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Preparation of plant extract (Brassica oleracea var.capitata)
The fresh leaves of B. oleracea var.capitata were collected and washed 
thoroughly under running water. Then, the leaves were blended with 
a blender. After that, the blended plant material was pressed to get 
the pure extract of B. oleracea var.capitata. This extract was treated 
with Kaolin. Then, the extract was concentrated on the hot plate. The 
pure organic part of the sample was thus prepared [7] and stored 
at 4–5°C. This final extract was redissolved in sterile water before 
experimentation for the evaluation of the antipsoriatic activity.
PRELIMINARY PHYTOCHEMICAL SCREENING
The standard screening test of the extract was performed for various 
plant constituents. The crude extract was screened for the presence 
or absence of secondary metabolites using standard procedures [8,9] 
[Table 1].
ACUTE ORAL TOXICITY
An acute toxicity study was carried out as per OECD-423 guidelines.
ANTIPSORIATIC ACTIVITY
All experimental procedures and protocols used in this study were 
reviewed by the Institutional Animal Ethical Committee (IAEC) and 
Committee for the purpose of control and supervision of Experiments 
Table 3: Effect of aqueous extract of Brassica oleracea var. capitata leaves and ethanolic extract of Mentha spicata leaves on 
heamotological parameters in imiquimod induced psoriasis
Heamotological parameters Normal Disease Standard BOAE MSEE
Topical Oral Low dose High dose
Neutrophils (%) 13.5±4.1 7.26±4.1 11.3±4.68b 8.1±4.1c 9.2±3.4c 8.6±5.2b 10.4±3.9c
Lymphocyte (%) 62.2±4.14 91.6±4.8 67.0±5.7c 85.6±3.7c 75.2±9.5b 81.8±7.5c 71.0±11.9b
Eosinophils (%) 2.7±1.78 7.3±1.2 2.2±1.3c 4.6±1.3c 4.0±1.5b 6.2±1.10c 2.2±1.3c
Monocyte (%) 2.12±1.60 7.0±1.5 1.9±1.43b 4.2±1.48c 2.2±1.3c 4.0±1.58b 1.84±1.35c
Hemoglobin (g/dl) 11.31±0.5 7.89±0.62 10.79±0.53c 9.38±0.53b 10.16±0.53b 9.66±0.49c 10.36±0.4c
RBC (milli/cumm) 4.4±0.7 2.11±0.61 3.97±0.47c 2.78±0.40c 3.7±0.5b 3.28±0.68a 3.61±0.3c
Platelets (lakhs/cumm) 2.65±0.4 1.65±0.3 2.51±0.65a 1.94±0.4c 2.21±0.4c 2.00±0.5b 2.31±0.40c
PCV 15.26±1.3 31.8±1.6 17.0±1.2c 23.4±1.83b 19.2±1.56c 21.8±1.6b 17.9±1.6c
MCV 43.35±1.03 54.8±1.5 44.9±1.04c 52.5±1.5c 49.3±1.45b 51.0±1.4b 46.2±1.0c
MCH 14.86±0.89 23.3±1.6 17.4±1.5c 22.1±1.3b 19.3±0.7c 21.3±0.8c 17.9±0.9b
MCHC 26.6±1.0 32.1±2.1c 27.0±0.8c 30.3±1.8a 29.0±1.3b 32.2±1.2c
All values were expressed as mean±SEM, (n=6). Statistical significance: ap<0.05, bp<0.01, cp<0.001 were compared with disease control (one-way ANOVA followed 
by Dunnet ҆s multiple comparision test). PCV: Packed cell volume, MCV: Mean corpuscular volume, MCH: Mean corpuscular hemoglobin, MCHC: Mean corpuscular 
hemoglobin concentration, RBC: Red blood cells, SEM: Standard error of mean, MSEE: Ethanolic extract of Mentha spicata leaves, BOAE: Aqueous extract of Brassica 
oleracea var. capitata leaves
Table 4: Effect of aqueous extract of Brassica oleracea var. capitata leaves and ethanolic extract of Mentha spicata leaves on skin in 
imiquimod induced psoriasis
Skin parameters Normal Disease Standard BOAE MSEE
Topical Oral Low High
Orthokeratosis (%) 62.3±1.2 12.18±2.02 60.04±2.3c 19.63±2.9b 40.6±2.2c 32.8±2.8b 55.4±1.9c
Drug activity (%) - - 54.01 5.18 24.31 18.08 32.1
Relative epidermal thickness (%) 71.4±4.6 100.0±9.02 67.5±5.18c 52.3±9.65a 56.9±4.0c 54.3±2.7c 65.87±3.7b
All values were expressed as mean±SEM, (n=6). Statistical significance: ap<0.05, bp<0.01, cp<0.001 were compared with disease control (one-way ANOVA followed by 
Dunnet ҆s multiple comparision test). SEM: Standard error of mean, MSEE: Ethanolic extract of Mentha spicata leaves, BOAE: Aqueous extract of Brassica oleracea var. 
capitata leaves
Table 2: Effect of aqueous extract of Brassica oleracea var. capitata leaves and ethanolic extract of Mentha spicata leaves on weight 
parameters in imiquimod induced psoriasis
Weight parameters Normal Control Standard BOAE MSEE
Topical Oral Low High
Body weight 24.25±1.1 17.4±0.98 23.0±0.85 19.4±1.06 20.95±1.04 20.2±1.5 21.8±1.3
Spleen weight 1.2±0.49 5.1±1.46 2.51±0.93 4.47±1.03 3.18±0.650 2.84±1.0 2.9±1.4
Spleen index 5.28±0.925 16.65±0.89 5.94±1.32 12.00±0.56 9.5±0.94 10.6±1.3 6.2±1.0
All values were expressed as mean±SEM, (n=6).Statistical significance: ap<0.05, bp<0.01, cp<0.001 were compared with disease control (one-way ANOVA followed by 
Dunnet ҆s multiple comparision test). SEM: Standard error of mean, MSEE: Ethanolic extract of Mentha spicata leaves, BOAE: Aqueous extract of Brassica oleracea var. 
capitata leaves
Table 1: The detected compounds in both the plant extracts












+ve: Presence of compounds, -ve: Absence of compounds. MSEE: Ethanolic 
extract of Mentha spicata leaves, BOAE: Aqueous extract of Brassica oleracea var. 
capitata leaves
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on Animals (CPCSEA) rules were in accordance with the guidelines of 
IAEC (Regd.No.1521/PO/a/11/CPCSEA). The anti-psoriatic activity 
of plant extracts was reviewed through different tests [Tables 2-9]. 
Male Swiss mice (weighing 20–30 g) at the age of 8 to 11 weeks were 
used for the study. Animals were allowed for free access to water and 
standard chow diet up to the end of the 23-day experimental period. 
Table 9: Effect of aqueous extract of Brassica oleracea var. capitata leaves and ethanolic extract of Mentha spicata leaves on antioxidants 
in Imiquimod induced psoriasis
Antioxidant parameters Normal Disease Standard BOAE MSEE
Topical Oral Low dose High dose
SOD (units/mg) 20.24±0.932 8.71±0.843 18.18±1.01c 12.68±1.8a 13.48±1.2b 14.98±0.943c 16.24±0.98b
CAT (units/mg) 6.85±0.6 2.01±0.932 4.63±0.683c 3.69±0.915b 4.02±0.74c 3.87±0.98a 4.29±0.87b
LPO (n.mol/mg) 2.09±0.587 15.31±0.73 4.83±0.673c 4.4±0.88a 3.84±0.72b 4.2±0.62b 3.86±0.54c
All values were expressed as mean±SEM, (n=6). Statistical significance: ap<0.05, bp<0.01, cp<0.001 were compared with disease control (one-way ANOVA followed by 
Dunnet ҆s multiple comparision test). SEM: Standard error of mean, MSEE: Ethanolic extract of Mentha spicata leaves, BOAE: Aqueous extract of Brassica oleracea var. 
capitata leaves
Table 8: Effect of aqueous extract of Brassica oleracea var. capitata leaves and ethanolic extract of Mentha spicata leaves on epidermal 
thickness in imiquimod induced psoriasis
Epidermal thickness Disease Standard BOAE MSEE
Topical Oral Topical Oral
On 7th day 4.3±0.34 4.0±0.45b 4.8±0.57a 4.2±0.78a 4.9±0.56b 3.9±0.34b
On 12th day 4.5±0.46 2.10±0.32c 4.3±0.34b 3.8±0.44b 4.0±0.60a 3.5±0.56b
On 21st day 4.8±0.54 1.10±0.22c 3.5±0.53b 2.75±0.46a 3.1±0.35b 1.54±0.23c
All values were expressed as mean±SEM, (n=6). Statistical significance: ap<0.05, bp<0.01, cp<0.001 were compared with disease control (one-way ANOVA followed by 
Dunnet ҆s multiple comparision test). SEM: Standard error of mean, MSEE: Ethanolic extract of Mentha spicata leaves, BOAE: Aqueous extract of Brassica oleracea var. 
capitata leaves
Table 7: Effect of aqueous extract of Brassica oleracea var. capitata leaves and ethanolic extract of Mentha spicata leaves on skin 
thickness in imiquimod induced psoriasis
Skin thickness Normal Disease Standard BOAE MSEE
Topical Oral Low dose High dose
On 7th day 0.12±0.01 1.51±0.11 1.43±0.11c 1.97±0.3a 2.01±0.1c 1.89±0.3a 2.4±0.3b
On 12th day 0.14±0.02 1.87±0.12 1.01±0.1c 1.8±0.1c 1.4±0.29a 1.63±0.1c 1.2±0.2b
On 21st day 0.11±0.03 2.03±0.2 0.39±0.1c 1.5±0.134c 1.2±0.2b 1±0.1c 1.01±0.1c
All values were expressed as mean±SEM, (n=6). Statistical significance: ap<0.05, bp<0.01, cp<0.001 were compared with disease control (one-way ANOVA followed by 
Dunnet ҆s multiple comparision test). SEM: Standard error of mean, MSEE: Ethanolic extract of Mentha spicata leaves, BOAE: Aqueous extract of Brassica oleracea var. 
capitata leaves
Table 6: Effect of aqueous extract of Brassica oleracea var. capitata leaves and ethanolic extract of Mentha spicata leaves on 
desquamation in imiquimod induced psoriasis
Desqumation Disease Standard BOAE MSEE
Topical Oral Low dose High dose
On 7th day 4.0±0.4 3.9±0.2c 4.2±0.3a 4.6±0.3b 3.7±0.2c 4.3±0.16c
On 12th day 4.5±0.2 2.4±0.1c 3.6±0.2b 2.4±0.27a 3.0±0.19c 2.4±0.2b
On 21th day 5.2±0.17 1.8±0.15c 2.9±0.3c 2.3±0.18b 2.9±0.14c 1.02±0.12c
All values were expressed as mean±SEM, (n=6). Statistical significance: aP<0.05, bp<0.01, cp<0.001 were compared with disease control (one-way ANOVA followed by 
Dunnet ҆s multiple comparision test). SEM: Standard error of mean, MSEE: Ethanolic extract of Mentha spicata leaves, BOAE: Aqueous extract of Brassica oleracea var. 
capitata leaves
Table 5: Effect of aqueous extract of Brassica oleracea var. capitata leaves and ethanolic extract of Mentha spicata leaves on erythema in 
imiquimod induced psoriasis
Erythema Disease Standard BOAE MSEE
Topical Oral Low High
On 7th day 4.0±0.4 3.9±0.2b 4.2±0.3b 4.6±0.3b 3.7±0.2c 4.3±0.16c
On 12th day 4.5±0.2 2.4±0.1c 3.6±0.2c 2.4±0.27b 3.0±0.19b 2.4±0.2b
On 21th day 5.2±0.17 1.8±0.15c 2.9±0.3a 2.3±0.18b 2.9±0.14c 1.02±0.12c
All values were expressed as mean±SEM, (n=6). Statistical significance: ap<0.05, bp<0.01, cp<0.001 were compared with disease control (one-way ANOVA followed by 
Dunnet ҆s multiple comparision test). SEM: Standard error of mean, MSEE: Ethanolic extract of Mentha spicata leaves, BOAE: Aqueous extract of Brassica oleracea var. 
capitata leaves
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antioxidant studies that were carried out are lipid peroxidation (LPO) 
[18], catalase (CAT) [19], and superoxide dismutase [20].
Hematological parameters
Blood was collected through retroorbital route and stored in K2 
ethylenediaminetetraacetic acid vial for the complete blood count. 
Blood was analyzed for the following parameters as hemoglobin (Hb %), 
red blood cell (RBC), lymphocytes, neutrophils, eosinophil, monocyte, 
platelet count, packed cell volume (PCV), mean corpuscular volume 
(MCV), mean corpuscular hemoglobin (MCH), MCH concentration 
(MCHC) were estimated with the help of hematology analyzer (Medonic 
CA620, Boule, Sweden).
Statistical analysis
The results are expressed as mean±standard error of the mean. 
Comparison between the treatment groups and control were performed 
using Graph pad prism06 version by ANOVA method followed by 
multiple comparisons of Dunnet’s method.
RESULTS
Effect of IMQ-induced psoriasis in mice
Morphological findings
Scales and redness on the skin of mice was observed after application 
of Imiquimod
Assessment of psoriasis using psoriasis area and severity index
Morphological characters and health status, such as water and 
food consumption, behavior signs, body weight, cardiovascular 
signs, and respiratory patterns of all mice were normal throughout 
the experimental period. Two or three days after starting the IMQ 
application, it was observed that the dorsal skin exhibited signs of 
erythema, scaling, and thickening (Fig. 2). Thereafter, the intensity 
of psoriasis-like symptoms of diseased mice progressively increased 
in severity until the end of the treatment (day 16). However, mice 
in Group I treated daily with Vaseline did not show any signs of 
inflammation on the dorsal skin (Fig. 1). The independent PASI scores 
showed the continuous increase in levels of inflammation after IMQ 
application from day 1 to day 7, before initiation of treatment with 
Retino-A, aqueous extract of B. oleracea var. capitata (BOAE), ethanolic 
extract of M. spicata (MSEE). The intensity of PASI scores reached a 
peak on the seventh day after IMQ treatment which indicates successful 
induction of psoriasis-like dermatitis in the IMQ-treated mice.
However, there was a statistically significant decrease in psoriasis-like 
symptoms beginning on day 9, the 2nd day after initiation of treatment 
with Retino-A (group III), BOAE (groups IV, V), MSEE (Groups VI, VII). 
These symptoms consistently declined until day 16. The individual 
The animals were divided into seven groups. Each group consists of five 
mice. All the animals were shaved on the back using hair removal cream 
(Veet). After 24 h of hair removal, 62.5 mg of Imiquimod (translating 
3.125 mg of active compound) was applied on the shaved back using 
the applicator brush for 7 consecutive days for all the animals except 
for normal group [10].
• Group-I: Normal control group of mice received normal saline and 
regular feed
• Group-II: Disease control group of mice. This group of animals was 
induced with Imiquimod 5% cream at a dose of 62.5 mg (translating 
3.125 mg of active compound) on the shaved back topically for 7 
consecutive days. Mice were given acetate in drinking water for 
7 days to enhance Imiquimod-induced skin inflammation [11]
• Group-III: Standard control group of mice was induced with psoriasis 
same as Group-II animals. On the 8th day, Retino-A 0.025% was 
applied topically for the other 16 days [12]
• Group-IV: This group was induced with psoriasis same as Group-II 
animals. On the 8th day, B. oleracea var.capitata extract was diluted 
with distilled water and given orally at a dose of 400 mg/kg b.wt. 
for 16 days
• Group-V: This group was induced with psoriasis same as Group-II 
animals. On the 8th day, B. oleracea var.capitata extract was applied 
topically as a 0.4% concentration for 16 days
• Group-VI: This group was induced with psoriasis same as Group-II 
animals. On the 8th day, M. spicata extract was diluted with distilled 
water and given orally at a dose of 200 mg/kg b.wt. for 16 days
• Group-VII: This group was induced with psoriasis same as Group-II 
animals. On the 8th day, M. spicata extract was diluted with distilled 
water and given orally at a dose of 400 mg/kg b.wt. for 16 days.
On every alternate day, the thickness of skin and ear thickness was 
measured using a digital micrometer (SLB Works). The increase in skin 
thickness was taken as a measure of skin inflammation [13].
Scoring severity of inflammation
The severity of inflammation on the back skin- an objective scoring 
system was developed based on the clinical Psoriasis Area and Severity 
Index (PASI). This is an online application. Erythema, induration, and 
desquamation were scored independently on a scale from 0 to 4: 0, 
none; 1, slight; 2, moderate; 3, marked; 4, very marked.
Assessment of body weight
Body weight of the animals is assessed before the experiment and on 
the last day after 2 h of treatment, animals were weighed, and weight 
was recorded [14].
Sample collection
At the end after 2 hs of final treatment mice were weighed then
• Blood was collected through retro-orbital route
• Then, animals were sacrificed by deep ether anesthesia, and back 
skin of mice was collected
• Then, the spleen was isolated.
Histopathological examination of skin
The skin that was isolated was stored in separate containers containing 
10% formalin in saline. Longitudinal histology sections of animal skin 
were and stained with hematoxylin-eosin [15,16].
Changes in spleen
The spleen from each mouse was isolated and was weighed. 
Splenomegaly was evaluated by calculating the ratio of the weight of 
the spleen to the body weight [17].
The spleen index is calculated using formula,
Spleen index=spleen weight/body weight × 100
Biochemical parameter estimations
Skin tissues were collected from the experimental animals, and the tissues 
were homogenized to carry out the In vivo antioxidant parameters. The Fig. 1: Normal
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PASI scores and the cumulative scores of all groups from days 1 to 16 
are depicted in Fig. 1-7. Comparing with the IMQ-treated group, BOAE, 
MSEE treated groups showed a significant inhibitory effect on IMQ-
induced psoriasis-like dermatitis. The route-dependent reduction in 
the PASI inflammatory symptoms was observed in the BOAE -treated 
groups at doses of 400 mg/kg b. wt. and dose-dependent reduction 
PASI inflammatory symptoms were observed in the BOAE -treated 
group at dose administrations of 100 mg/kg b.wt., 400 mg/kg b.wt. of 
mice. The marked reduction of PASI scores of Retino-A treated group 
was comparable to the 400 mg/kg b.wt. treated group.
Histological slides
The histopathology slides helped in evaluating different parameters 
like inflammatory cells, neutrophils, etc,. [Fig.8] [34]. 
Fig. 7: Ethanolic extract of Mentha spicata high dose
Fig. 2: Diseased
Fig. 3: Standard
Fig. 4: Aqueous extract of Brassica oleracea var. capitata topical
Fig. 5: Aqueous extract of Brassica oleracea var. capitata oral
Fig. 6: Ethanolic extract of Mentha spicata low dose
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DISCUSSION
Swiss albino male mice were used in this experiment due to its 
better tolerance level to Imiquimod compared to female [10]. As the 
autoantigen causing psoriasis is not known, there is no permanent cure 
for this disease. The medical care whichever available in the market is 
treating the disease temporarily.
Natural plant ingredients are often used as novel therapeutic agents to 
control the inflammation with reducing side effects. As B. oleracea var.
capitata and M. spicata was used traditionally, but there is no reported 
data so an attempt was made to evaluate the antipsoriatic activity of 
B. oleracea var.capitata and M. spicata [5,6].
Morphological findings and calculating PSAI confirms the attack of 
psoriasis-like dermatitis [21]. The decrease of the spleen weight/body 
weight ratio and cellularity of PALS after treatment with BOAE,MSEE in 
the IMQ-induced psoriasis-like dermatitis mice may be suggestive of a 
deficit in T-independent humoral immune responses [22]. Low number 
of neutrophils in the blood indicates the presence of infection [23,24]. 
Increase in lymphocytes that the immune system is working heavily, 
which is resulting in hyperproliferation of skin cells [25]. Eosinophils 
provide inflammatory signals that accelerate the pathogenesis 
of psoriasis [26]. High levels of monocytes indicate autoimmune 
disorders [27]. In auto-immune diseases, the immune system attacks 
and destroys RBC, platelets [28] and platelets may get trapped in the 
spleen [29]. PCV, MCV, MCH, and MCHC results indicate deranged 
pattern of iron status [30]. The decrease in the degree of orthokeratosis 
indicates destruction of granular layer [31]. Increase in erythema, 
desquamation, and skin thickness shows the presence of psoriasis 
morphologically [21]. If oxidative stress is persisting, or its level very 
high, the protein damage became profound and a decreased superoxide 
dismutase, CAT activity may occur [32]. LPO is a useful marker of 
oxidative stress because it is linked to increased production of ROS [33]. 
The histological studies reveal that the skin section treated/induced 
with Imiquimod showed a degenerative changes in skin tissue shows 
thickened epidermis, increased keratinization decrease in percentage of 
orthokeratotic regions, elongation of rette ridges, capillary loop dilation 
with minimal grade lesion of Munro ҆s microabcess, vacuolization 
which indicates the severe damage of skin tissue. Animals treated with 
Retino-A and BOAE, MSEE shows normal cytoarchitecture of skin tissue 
indicates regenerative changes [34].
CONCLUSION
This study showed that the aqueous extract of B. oleracea. var.
capitata and ethanolic extract of M. spicata leaves exhibits a 
significant antipsoriatic activity. Route of administration and also 
Dose dependently decreased the relative epidermal thickness of 
animal skin as well as other histopathology features. Hematological 
parameters have also shown that these plant extracts play a prominent 
role in the recovery of psoriatic-like symptoms. The study implies that 
B. oleracea e var.capitata and M. spicata leaves could be used as natural 
therapeutic drugs to prevent complications related to psoriasis and 
authentifies the folk claim of the plant in the use of traditional medicine 
for the treatment of psoriasis. Additional clinical investigation of 
these extracts is needed to evaluate the efficacy and safety of their 
application as dietary supplements with health benefits to psoriasis 
patients. Further molecular level investigation is needed to prove its 
antipsoriatic activity.
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